Amryt Pharma plc provided revenue guidance for the full year 2022. For the year, Company expects revenue in the range of $260 million to $270 million which represents growth of 17% to 21% on Fiscal Year 2021.
1st Jan change | Capi. | |
---|---|---|
-1.85% | 8.99TCr | |
-1.05% | 3.76TCr | |
-11.20% | 3.28TCr | |
+61.85% | 2.65TCr | |
-20.75% | 1.43TCr | |
-6.35% | 1.3TCr | |
-11.42% | 1.19TCr | |
-47.67% | 1.08TCr | |
+5.99% | 911.12Cr |